PMID- 31588926 OWN - NLM STAT- MEDLINE DCOM- 20200309 LR - 20211224 IS - 1643-3750 (Electronic) IS - 1234-1010 (Print) IS - 1234-1010 (Linking) VI - 25 DP - 2019 Oct 7 TI - Aggravation of Cerebral Ischemia/Reperfusion Injury by Peroxisome Proliferator-Activated Receptor-Gamma Deficiency via Endoplasmic Reticulum Stress. PG - 7518-7526 LID - 10.12659/MSM.915914 [doi] AB - BACKGROUND Ischemic stroke is a dominant contributor to disability and mortality worldwide and is recognized as an important health concern. As a transcription factor triggered via stress, peroxisome proliferator-activated receptor-gamma (PPAR-gamma) has a crucial impact on differentiation, cell death, and cell growth. However, the role of PPAR-gamma and its precise mechanism in cerebral ischemia injury (CII) remain unclear. MATERIAL AND METHODS The male C57Bl/6 mice (12 weeks old, n=52) were subjected to middle cerebral artery occlusion (MCAO). Infarct volume was evaluated by 2, 3, 5-Triphenyltetrazolium chloride staining. Cell apoptosis was measured by terminal dUTP nick-end labeling (TUNEL) staining. The expression of apoptotic-related protein was examined by Western blotting. Neuron2A cells were transfected with PPAR-gamma-specific siRNA and then were subjected to oxygen-glucose exhaustion and reoxygenation. RESULTS It was observed that PPAR-gamma-deficient mice displayed extended infarct trigon in the MCAO stroke model. Neuronal deficiency was more severe in PPAR-gamma-deficient models. Additionally, expression of cell death-promoting Bcl-2 associated X and active caspase-3 was reinforced, while that of cell death-counteracting Bcl-2 was repressed in PPAR-gamma-deficient mice. This was characterized by reinforced endoplasmic reticulum (ER) stress reactions in in vivo brain specimens as well as in vitro neurons in ischemia/reperfusion (I/R) injury. CONCLUSIONS This research proved that PPAR-gamma protected the brain from cerebral I/R injury by repressing ER stress and indicated that PPAR-gamma is a potential target in the treatment of ischemia. FAU - Chen, Yueping AU - Chen Y AD - Clinical Laboratory, The Third Affiliated Hospital of Wenzhou Medical University, Ruian, Zhejiang, China (mainland). FAU - Liu, Shihui AU - Liu S AD - Department of Neurology, Linyi Central Hospital, Linyi, Shandong, China (mainland). FAU - Chen, Guangyong AU - Chen G AD - Department of Neurology, The Third Affiliated Hospital of Wenzhou Medical University, Ruian, Zhejiang, China (mainland). LA - eng PT - Journal Article PT - Retracted Publication DEP - 20191007 PL - United States TA - Med Sci Monit JT - Medical science monitor : international medical journal of experimental and clinical research JID - 9609063 RN - 0 (PPAR gamma) SB - IM RIN - Med Sci Monit. 2021 Nov 01;28:e935290. PMID: 34719667 MH - Animals MH - Apoptosis/physiology MH - Brain/metabolism MH - Brain Ischemia/*metabolism/pathology MH - Disease Models, Animal MH - Endoplasmic Reticulum/physiology MH - Endoplasmic Reticulum Stress/physiology MH - Infarction, Middle Cerebral Artery/metabolism MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Neurons/metabolism MH - PPAR gamma/*metabolism MH - Reperfusion Injury/*metabolism/pathology MH - Stroke/metabolism PMC - PMC6792513 EDAT- 2019/10/08 06:00 MHDA- 2020/03/10 06:00 PMCR- 2019/10/07 CRDT- 2019/10/08 06:00 PHST- 2019/10/08 06:00 [entrez] PHST- 2019/10/08 06:00 [pubmed] PHST- 2020/03/10 06:00 [medline] PHST- 2019/10/07 00:00 [pmc-release] AID - 915914 [pii] AID - 10.12659/MSM.915914 [doi] PST - epublish SO - Med Sci Monit. 2019 Oct 7;25:7518-7526. doi: 10.12659/MSM.915914.